A clinical trial to maintain glycemic control in youth with type 2 diabetes.

Authors

Philip S. Zeitler, University of Colorado, Denver
Kathryn Hirst, George Washington University
Laura Pyle, George Washington University
Barbara Linder, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
Kenneth Copeland, University of OklahomaFollow
Silva A. Arslanian, Children's Hospital of Pittsburgh
Leona Cuttler, Case Western Reserve University
David M. Nathan, Massachusetts General Hospital
Sherida Tollefsen, St. Louis University
Denise E. Wilfley, Washington University School of Medicine in St. Louis
Francine R. Kaufman, Children's Hospital Los Angeles

Document Type

Journal Article

Publication Date

6-14-2012

Journal

New England Journal of Medicine

Volume

Volume 366, Issue 24

Inclusive Pages

2247-2256

Keywords

Diabetes Mellitus; Type 2--drug therapy; Hypoglycemic Agents--therapeutic use; Metformin--therapeutic use; Thiazolidinediones--therapeutic use

Comments

This is an open access PubMed Central article. Click on link for full-text access.

APA Citation

Zeitler, P., Hirst, K., Pyle, L., Linder, B., Copeland, K., Arslanian, S., . . . Kaufman, F. (2012). A clinical trial to maintain glycemic control in youth with type 2 diabetes. New England Journal of Medicine, 366(24), 2247-2256.

Peer Reviewed

1

Open Access

1